XCUR – Exicure Inc.
Exicure, Inc.XCUR
$2.85Name : Exicure, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $18,165,720.00
EPSttm : -1.5
Exicure, Inc.
$2.85
4.68%$0.14
XCUR — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
0.77
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
2.85
Target Price
10.33
Analyst Recom
1
Performance Q
-30.83
Upside
-802.5%
Beta
3.55
Ticker: XCUR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-05-11 | XCUR | 3.28 | N/A | N/A | 0 |
| 2026-05-12 | XCUR | 3.14 | N/A | N/A | 0 |
| 2026-05-13 | XCUR | 3.08 | N/A | N/A | 0 |
| 2026-05-14 | XCUR | 3.15 | N/A | N/A | 0 |
| 2026-05-15 | XCUR | 2.83 | N/A | N/A | 0 |
| 2026-05-18 | XCUR | 2.92 | N/A | N/A | 0 |
| 2026-05-19 | XCUR | 2.9 | N/A | N/A | 0 |
| 2026-05-20 | XCUR | 2.99 | N/A | N/A | 0 |
| 2026-05-21 | XCUR | 2.76 | N/A | N/A | 0 |
| 2026-05-22 | XCUR | 2.81 | N/A | N/A | 0 |
| 2026-05-26 | XCUR | 2.71 | N/A | N/A | 0 |
| 2026-05-27 | XCUR | 2.76 | N/A | N/A | 0 |
| 2026-05-28 | XCUR | 2.97 | N/A | N/A | 0 |
| 2026-05-29 | XCUR | 3.19 | N/A | N/A | 0 |
| 2026-06-02 | XCUR | 3.11 | N/A | N/A | 0 |
| 2026-06-03 | XCUR | 3.14 | N/A | N/A | 0 |
| 2026-06-04 | XCUR | 2.96 | N/A | N/A | 0 |
| 2026-06-05 | XCUR | 3.01 | N/A | N/A | 0 |
| 2026-06-08 | XCUR | 2.93 | N/A | N/A | 0 |
| 2026-06-09 | XCUR | 2.92 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-05-11 | XCUR | 3.29 | - | - | - |
| 2026-05-12 | XCUR | 3.24 | - | - | - |
| 2026-05-13 | XCUR | 3.00 | - | - | - |
| 2026-05-14 | XCUR | 3.19 | - | - | - |
| 2026-05-15 | XCUR | 2.94 | - | - | - |
| 2026-05-18 | XCUR | 3.00 | - | - | - |
| 2026-05-19 | XCUR | 2.81 | - | - | - |
| 2026-05-20 | XCUR | 3.00 | - | - | - |
| 2026-05-21 | XCUR | 2.73 | - | - | - |
| 2026-05-22 | XCUR | 2.70 | - | - | - |
| 2026-05-26 | XCUR | 2.70 | - | - | - |
| 2026-05-27 | XCUR | 2.69 | - | - | - |
| 2026-05-28 | XCUR | 2.94 | - | - | - |
| 2026-05-29 | XCUR | 3.15 | - | - | - |
| 2026-06-01 | XCUR | 3.26 | - | - | - |
| 2026-06-02 | XCUR | 3.19 | - | - | - |
| 2026-06-03 | XCUR | 3.12 | - | - | - |
| 2026-06-04 | XCUR | 3.02 | - | - | - |
| 2026-06-05 | XCUR | 2.94 | - | - | - |
| 2026-06-08 | XCUR | 3.01 | - | - | - |
| 2026-06-09 | XCUR | 2.85 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-05-11 | XCUR | -50.00 | -30.13 | 1.38 |
| 2026-05-12 | XCUR | -50.00 | -30.13 | 1.24 |
| 2026-05-13 | XCUR | -50.00 | -30.13 | 1.24 |
| 2026-05-14 | XCUR | -50.00 | -30.13 | 1.24 |
| 2026-05-15 | XCUR | -50.00 | -30.13 | 1.24 |
| 2026-05-18 | XCUR | -50.00 | -22.87 | 1.24 |
| 2026-05-19 | XCUR | -50.00 | -22.87 | 1.24 |
| 2026-05-20 | XCUR | -50.00 | -22.87 | 1.24 |
| 2026-05-21 | XCUR | -50.00 | -22.87 | 1.24 |
| 2026-05-22 | XCUR | -50.00 | -22.87 | 1.24 |
| 2026-05-26 | XCUR | -50.00 | 0.78 | 1.24 |
| 2026-05-27 | XCUR | -50.00 | 0.78 | 1.24 |
| 2026-05-28 | XCUR | -50.00 | 0.78 | 0.77 |
| 2026-05-29 | XCUR | -50.00 | 0.78 | 0.77 |
| 2026-06-02 | XCUR | -50.00 | -0.01 | 0.77 |
| 2026-06-03 | XCUR | -49.99 | -0.01 | 0.77 |
| 2026-06-04 | XCUR | -50.00 | -0.01 | 0.77 |
| 2026-06-05 | XCUR | -50.00 | -0.01 | 0.77 |
| 2026-06-08 | XCUR | -50.00 | -0.01 | 0.77 |
| 2026-06-09 | XCUR | -50.00 | -0.01 | 0.77 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
-50
Institutional Transactions
-0.01
Beta
3.55
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
3
Growth Score
Sentiment Score
23
Actual DrawDown %
99
Max Drawdown 5-Year %
-99.4
Target Price
10.33
P/E
Forward P/E
PEG
P/S
P/B
8.66
P/Free Cash Flow
EPS
-1.54
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.19
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
XCUR
Healthcare
$2.85
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
41.4
Range 1M
18.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
0%
EPS NY
0%
52W%
2%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+262.5% upside
Upside
+262.5%
Quality
3
Exicure, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 2
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
XCUR
Latest News
—
Caricamento notizie per XCUR…
stock quote shares XCUR – Exicure Inc. Stock Price stock today
news today XCUR – Exicure Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch XCUR – Exicure Inc. yahoo finance google finance
stock history XCUR – Exicure Inc. invest stock market
stock prices XCUR premarket after hours
ticker XCUR fair value insiders trading